• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柯萨奇病毒 A10 引起沙鼠肌肉损伤:一种新型抗病毒评价动物模型的构建。

Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation.

机构信息

Key Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Zhejiang Pukang Biotechnology Co., LTD., Hangzhou, China.

出版信息

Virus Res. 2020 Sep;286:198067. doi: 10.1016/j.virusres.2020.198067. Epub 2020 Jun 15.

DOI:10.1016/j.virusres.2020.198067
PMID:32553610
Abstract

The morbidity and mortality of coxsackievirus A10 (CVA10)-associated hand, foot, and mouth disease (HFMD) have been increasing in recent years, while few studies on the vaccine and animal model of CVA10 have been reported. Here, we first established a CVA10-infected gerbil model and employed it to evaluate the immunoprotective effect of an inactivated CVA10 vaccine. The results showed that gerbils up to the age of 14 days were fully susceptible to CVA10, and all died within five days post-infection by intraperitoneal inoculation. Lethargy, wasting, hind-limb paralysis, and even death could be observed in the CVA10-infected gerbils. Pathological examination suggested that CVA10 has a strong tropism toward muscle tissue, and muscle bundle fracture and muscular fibers necrosis were observed in the limb muscles. Additionally, active immunization results showed that gerbils immunized with the inactivated CVA10 vaccine were 100 % protected from lethal CVA10 challenge. The antisera from vaccinated gerbils also showed high neutralizing titers against CVA10. Based on these results, the CVA10-infected gerbil model was a suitable tool for analyzing the pathogenesis of CVA10 and assessing the protective efficacy of CVA10 candidate vaccines.

摘要

近年来,柯萨奇病毒 A10(CVA10)相关手足口病(HFMD)的发病率和死亡率一直在上升,而关于 CVA10 的疫苗和动物模型的研究却很少报道。在这里,我们首次建立了 CVA10 感染沙鼠模型,并将其用于评估 CVA10 灭活疫苗的免疫保护效果。结果表明,14 日龄以内的沙鼠对 CVA10 完全易感,腹腔接种后 5 天内全部死亡。感染 CVA10 的沙鼠表现出嗜睡、消瘦、后肢瘫痪,甚至死亡。病理检查表明 CVA10 对肌肉组织具有很强的嗜性,在四肢肌肉中观察到肌束断裂和肌纤维坏死。此外,主动免疫结果表明,用 CVA10 灭活疫苗免疫的沙鼠可 100%免受致死性 CVA10 攻击。接种沙鼠的血清也显示出针对 CVA10 的高中和滴度。基于这些结果,CVA10 感染沙鼠模型是分析 CVA10 发病机制和评估 CVA10 候选疫苗保护效果的合适工具。

相似文献

1
Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation.柯萨奇病毒 A10 引起沙鼠肌肉损伤:一种新型抗病毒评价动物模型的构建。
Virus Res. 2020 Sep;286:198067. doi: 10.1016/j.virusres.2020.198067. Epub 2020 Jun 15.
2
Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.甲醛灭活全病毒疫苗和抗病毒药物在柯萨奇病毒A10感染小鼠模型中的保护效力
J Virol. 2017 Jun 9;91(13). doi: 10.1128/JVI.00333-17. Print 2017 Jul 1.
3
A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation.用于抗病毒评估的柯萨奇病毒 A10 感染新生鼠模型。
Antiviral Res. 2017 Aug;144:247-255. doi: 10.1016/j.antiviral.2017.06.008. Epub 2017 Jun 15.
4
Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.灭活柯萨奇病毒A10实验性疫苗可保护小鼠免受致命病毒攻击。
Vaccine. 2016 Sep 22;34(41):5005-5012. doi: 10.1016/j.vaccine.2016.08.033. Epub 2016 Aug 22.
5
Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.鉴定一种可诱导针对柯萨奇病毒 A6 和 A10 产生平衡保护免疫的灭活全病毒二价疫苗在小鼠中的作用。
Vaccine. 2018 Nov 12;36(46):7095-7104. doi: 10.1016/j.vaccine.2018.09.069. Epub 2018 Oct 11.
6
A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.用于评估抗病毒和疫苗效力的柯萨奇病毒A6感染新生小鼠模型
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02450-16. Print 2017 May 1.
7
Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.柯萨奇病毒 A10 在小鼠体内的增殖特性及实验性灭活疫苗的免疫保护作用。
Biomed Pharmacother. 2021 Nov;143:112212. doi: 10.1016/j.biopha.2021.112212. Epub 2021 Sep 27.
8
An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates.用于评估潜在柯萨奇病毒 A16 疫苗候选物的成年沙鼠模型。
Vaccine. 2019 Aug 23;37(36):5341-5349. doi: 10.1016/j.vaccine.2019.07.046. Epub 2019 Jul 24.
9
Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.评价单价和双价疫苗对新生鼠致死性肠道病毒 71 型和柯萨奇病毒 A16 感染的效果。
Hum Vaccin Immunother. 2014;10(10):2885-95. doi: 10.4161/hv.29823.
10
A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection.病毒样颗粒疫苗可预防小鼠柯萨奇病毒 A10 致死性感染。
Antiviral Res. 2018 Apr;152:124-130. doi: 10.1016/j.antiviral.2018.02.016. Epub 2018 Feb 20.

引用本文的文献

1
Pathological characteristics of a murine oral coxsackievirus A10 infection model.小鼠口腔柯萨奇病毒A10感染模型的病理学特征
J Virol. 2025 Jul 22;99(7):e0093725. doi: 10.1128/jvi.00937-25. Epub 2025 Jul 1.
2
Pathogenicity and transcriptomic profiling reveals immunology molecular hallmarks after CA10 virus infection.CA10 病毒感染后的致病机制和转录组特征分析揭示了免疫学的分子特征。
Animal Model Exp Med. 2024 Oct;7(5):717-731. doi: 10.1002/ame2.12415. Epub 2024 May 15.
3
Human SCARB2 Acts as a Cellular Associator for Helping Coxsackieviruses A10 Infection.
人源 SCARB2 作为一种细胞辅助因子促进柯萨奇病毒 A10 感染
Viruses. 2023 Apr 8;15(4):932. doi: 10.3390/v15040932.
4
Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice.肠道病毒 A10 疫苗在小鼠体内的体液和细胞免疫原性及效果。
Emerg Microbes Infect. 2023 Dec;12(1):e2147022. doi: 10.1080/22221751.2022.2147022.
5
From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD).从单价疫苗到多价疫苗,探索预防手足口病(HFMD)的潜在策略。
Virol Sin. 2021 Apr;36(2):167-175. doi: 10.1007/s12250-020-00294-3. Epub 2020 Sep 30.